Les lipides et les cancers urologiques
- approches épidémiologiques.
L’importance du temps immortel

Les lipides et les cancers urologiques - approches épidémiologiques. L’importance du temps immortel

Show other versions (1)

Objectif: Définir l’effet des lipides et du traitement de la dyslipidémie sur les cancers de la prostate et de la vessie en utilisant différents devis d’étude et en tenant compte de la présence de plusieurs biais, particulièrement le biais du temps immortel. Devis: Le premier volet utilise un devi...

Full description

Bibliographic Details
Main Author:	Fradet, Vincent
Other Authors:	Le Lorier, Jacques
Language:	fr
Published:	2013
Subjects:	cancer de la prostate cancer de la vessie lipides acides gras oméga-3 statines hypolipidémiants étude observationnelle données administratives biais du temps immortel prostate cancer bladder cancer lipids omega-3 fatty acids statins hypolipidemic drugs observationnal study administrative database immortal time bias Health Sciences - Public Health / Sciences de la santé - Santé publique (UMI : 0573)
Online Access:	http://hdl.handle.net/1866/9792

Similar Items

Les lipides et les cancers urologiques - approches épidémiologiques. L’importance du temps immortel
by: Fradet, Vincent
Published: (2013)

Associations between Statin/Omega3 Usage and MRI-Based Radiomics Signatures in Prostate Cancer
by: Yu Shi, et al.
Published: (2021-01-01)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
by: Juan Morote, et al.
Published: (2014-08-01)

Statin use and mortality of patients with prostate cancer: a meta-analysis
by: Meng Y, et al.
Published: (2016-03-01)

Eruption of palmoplantar pustular psoriasis in patient treated with anti-androgen therapy for prostate cancer and aggravation of lesions after statin treatment
by: Pietrzak Aldona, et al.
Published: (2014-10-01)

New hypolipidemic drugs from the group of reductase inhibitors GMG-CoA
by: A V Susekov, et al.
Published: (2003-02-01)

Les inhibiteurs de l'HMG-CoA réductase en prévention de la maladie d'Alzheimer : minimiser l'effet du biais d'indication
by: Lavoie, Frédéric
Published: (2016)

Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study
by: Li K, et al.
Published: (2019-02-01)

Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
by: Dennie Meijer, et al.
Published: (2019-07-01)

Statins Prevent Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Single-center Retrospective Study with a Median Follow-up of 51.20 Months
by: Jarimba R, et al.
Published: (2020-09-01)

Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
by: Mark A Moyad, et al.
Published: (2015-01-01)

La fabrique du sujet vulnérable : étude sur l'expérience du cancer de la prostate
by: Braverman, Louis
Published: (2017)

Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial
by: Marie-Hélène Guertin, et al.
Published: (2018-01-01)

The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins
by: Julia K. Bird, et al.
Published: (2018-06-01)

Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study
by: Kai Wang, et al.
Published: (2019-12-01)

Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review
by: Ping Tan, et al.
Published: (2017-01-01)

Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins
by: Yosuke Furuya, et al.
Published: (2016-06-01)

Statins induce cell apoptosis through a modulation of AKT/FOXO1 pathway in prostate cancer cells
by: Deng JL, et al.
Published: (2019-07-01)

The potential use of simvastatin for cancer treatment: A review
by: Jaqueline Aparecida Duarte, et al.
Published: (2021-09-01)

Les facteurs critiques de succès des fusions d'établissements : le cas de centres d'hébergement et de soins de longue durée
by: Martin, Denis
Published: (1992)

Les facteurs critiques de succès des fusions d'établissements : le cas de centres d'hébergement et de soins de longue durée
by: Martin, Denis
Published: (1992)

L'influence du niveau de participation au processus de planification stratégique sur les plans stratégiques des centres hospitaliers publics : étude de cas
by: Poulin, Pierre
Published: (1993)

L'influence du niveau de participation au processus de planification stratégique sur les plans stratégiques des centres hospitaliers publics : étude de cas
by: Poulin, Pierre
Published: (1993)

The risk of cancer in statin users : a clinical and genetic approach
by: Sun, Maxine
Published: (2019)

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
by: Federica Iannelli, et al.
Published: (2020-10-01)

Evaluation de la sécurité d’emploi des médicaments modulant les androgènes dans les maladies prostatiques, une approche pharmaco-épidémiologique
by: Scailteux, Lucie-Marie
Published: (2017)

IMPROVE-IT
by: Eldrin F. Lewis, MD, MPH, et al.
Published: (2020-09-01)

Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
by: Adele Chimento, et al.
Published: (2019-01-01)

Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice
by: Kretzer IF, et al.
Published: (2016-03-01)

Clinically complete response to abiraterone acetate in a patient with metastatic castration‐resistant prostate cancer
by: Yoshinori Yanai, et al.
Published: (2019-07-01)

TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
by: V. A. Korneva, et al.
Published: (2015-09-01)

Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer
by: Xiang‐Lin Tan, et al.
Published: (2020-04-01)

Mécanismes d'action des androgènes sur l'expression des récepteurs de la famille du récepteur à l'EGF dans les cellules cancéreuses prostatiques : implication dans l'évolution des tumeurs vers l'hormono-indépendance. Mots-clés
by: Pignon, Jean-Christophe
Published: (2010)

Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial
by: Paavo V.H. Raittinen, et al.
Published: (2021-06-01)

La concertation entre les C.L.S.C. et les C.H.S.C.D. pour accroître leur complémentarité et améliorer les services à la clientèle agée en perte d'autonomie
by: Boucher, Colette
Published: (1995)

La concertation entre les C.L.S.C. et les C.H.S.C.D. pour accroître leur complémentarité et améliorer les services à la clientèle agée en perte d'autonomie
by: Boucher, Colette
Published: (1995)

Intervention biologique dans les cancers hormono-dépendants.
by: Pouget, Mélanie
Published: (2016)

Caractéristiques épidémiologiques du cancer de la vessie chez la femme en Tunisie
by: M. Cherif, et al.
Published: (2016-06-01)

Impact de l'environnement chimique sur la prise en charge de molécules à visée anti-cancéreuse : effet du cadmium sur l'efficacité potentielle de la Phenstatine et de ses métabolites dans le traitement du cancer de la prostate
by: Le Broc, Delphine
Published: (2011)

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer
by: Angela Maselli, et al.
Published: (2019-07-01)